Cargando…
Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
BACKGROUND: Colorectal cancer (CRC) is the second leading cause of death among cancers in the United States. Although individuals diagnosed early have a greater than 90 % chance of survival, more than one-third of individuals do not adhere to screening recommendations partly because the standard dia...
Autores principales: | Baxter, Nielson T., Ruffin, Mack T., Rogers, Mary A. M., Schloss, Patrick D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823848/ https://www.ncbi.nlm.nih.gov/pubmed/27056827 http://dx.doi.org/10.1186/s13073-016-0290-3 |
Ejemplares similares
-
DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model
por: Baxter, Nielson T., et al.
Publicado: (2016) -
Normalization of the microbiota in patients after treatment for colonic lesions
por: Sze, Marc A., et al.
Publicado: (2017) -
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis
por: Zackular, Joseph P., et al.
Publicado: (2015) -
Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021) -
Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status and Cannot Be Predicted Based on Bacterial Community Structure
por: Sze, Marc A., et al.
Publicado: (2019)